Three-year dynamics and unsolved problems of lipid-lowering therapy
Aim. To study the lipid-lowering therapy, the adequacy of its control, as well as the awareness of patients at a high cardiovascular risk of atherosclerosis problems and the dynamics of these parameters in 3 years. Material and methods. Patients with dyslipidemia (113 patients in 2011 and 100 patien...
Saved in:
| Main Author: | V. A. Sergeeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study
by: Andrej Belančić, et al.
Published: (2025-06-01) -
Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident
by: S. A. Boytsov, et al.
Published: (2022-01-01) -
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01) -
MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01) -
Clinical, lipid-lowering, and pleiotropic effectiveness of rosuvastatin: a review of the GALAXY programme results
by: A. N. Britov, et al.
Published: (2011-02-01)